 Home > Active Ingredient News > Study of Nervous System > Yiling Pharmaceutical's Aniprofen Injection Formally Started Phase III Clinical Trial

Yiling Pharmaceutical's Aniprofen Injection Formally Started Phase III Clinical Trial

 Last Update: 2021-05-02
 Source: Internet
 Author: User

Tags

sheba medical center

innovative packaging company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 13, Yiling Pharmaceutical issued an announcement that the company's Phase III clinical trial plan for the company's 1.

It is reported that ibuprofen aniline injection is a non-steroidal town analgesics, intended for surgery, a variety of pain, trauma, lumbago (acute, chronic exacerbations), gout made for, neuralgia, kidney and urinary Stone pain and so on.

It is a non-steroidal town analgesics, intended for surgery, a variety of pain, trauma, lumbago (acute, chronic exacerbations), gout made for, neuralgia, urinary calculi and renal pain.
Aniline ibuprofen injection in 2017 and in 2018 completed Phase I clinical First Affiliated Hospital of Jilin University trials.
From April 2019 to June 2020, the Phase II clinical trial was completed in 8 centers including the Third Xiangya Hospital of Central South University .

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.